Report: Israel in Talks With AstraZeneca for Potential COVID-19 Vaccine
Error: Contact form not found.
by Reuters and Algemeiner Staff

A sign is seen at an AstraZeneca site in Macclesfield, England, May 19, 2014. Photo: Reuters / Phil Noble.
Israel is in advanced negotiations with AstraZeneca for the future purchase of its experimental COVID-19 vaccine, Israel’s YNET news website reported on Monday.
A Health Ministry spokesman said the ministry “does not disclose contacts being held in this sensitive matter.”
The experimental coronavirus vaccine being developed by AstraZeneca and Oxford University was safe and produced an immune response in early-stage clinical trials, data showed on Monday, keeping alive the hope it could be in use by the end of the year.
AstraZeneca was not reachable for immediate comment.
Israel has already signed such an agreement with Moderna Inc for its vaccine candidate.
Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says









